Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Fortune
Fortune
Lindsey Leake

Got COVID? Here are the updated 2024 isolation guidelines

As of March 2024, the Centers for Disease Control and Prevention no longer advises a five-day isolation period when you test positive for COVID-19, but recommends taking other precautions once your symptoms subside. (Credit: Drazen Zigic—Getty Images)

Two lines appear on the test card, 15 minutes after you’ve swabbed the depths of your nostrils and swirled the contents in a plastic tube. You’ve got COVID.

As recently as February, a positive rapid test would’ve meant five days of isolation, away from work, school, and/or other obligations that involve going out in public. Not anymore. In March, the Centers for Disease Control and Prevention (CDC) updated its COVID isolation guidelines based on symptoms, not time since testing positive.

The guidelines shifted in part to match those of other common respiratory viral illnesses, including the flu and respiratory syncytial virus (RSV). The CDC now says you’re cleared to resume normal activities when the following are both true for at least 24 hours:

  • Your symptoms are getting better overall
  • You haven’t had a fever (and aren’t using fever-reducing medication)

Bottom line: If you’re sick, stay home. If your symptoms persist, you may end up isolating for five or more days after all, but you’ll be doing your part to protect your loved ones, coworkers, and others in your community from infection.

If you absolutely can’t stay home while ill, be sure to wear a mask, says Dr. Robert Hopkins Jr., medical director of the National Foundation for Infectious Diseases (NFID).

“Those who have symptoms of a respiratory virus—cough, sneezing, body aches, nasal congestion with or without fever—should test for COVID-19—and influenza when influenza is circulating in their communities,” Hopkins tells Fortune via email. “If the test is positive, call a health care professional who may prescribe antiviral medication to help lessen their symptoms and the risk for severe illness.”

Paxlovid (nirmatrelvir with ritonavir), the oral COVID antiviral manufactured by Pfizer, cuts your risk of hospitalization by over half and risk of death by 75%, according to the CDC. The agency considers people with conditions such as asthma, diabetes, or obesity at high risk of severe infection, and therefore candidates for Paxlovid. Ask your doctor if this or another antiviral treatment is right for you.

View this interactive chart on Fortune.com

“To care about whether or not what you may do could sicken or injure another person, there’s a moral and ethical issue here,” Tuckson said. “Some of us want to be heroes and she-roes: ‘I was sick as a dog and I went to work anyway, and that shows you how tough I am.’ 

“As opposed to the other narrative is, ‘Let me tell you how rude I am, and how willing I am to infect other people just to show you what a great ego I am.’ Which side of that equation do you want to be on?”

For more on COVID-19:

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.